Stella Pharma Corporation (4888.T)
JPY 333.0
(2.15%)
JPY 333.0
(2.15%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 773.29 Million JPY | -17.14% |
| 2022 | 933.3 Million JPY | -14.64% |
| 2021 | 1.09 Billion JPY | -12.77% |
| 2020 | 1.25 Billion JPY | -11.32% |
| 2019 | 1.41 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 733.29 Million JPY | -5.17% |
| 2023 Q3 | 813.29 Million JPY | -4.69% |
| 2023 FY | 773.29 Million JPY | -17.14% |
| 2023 Q2 | 853.29 Million JPY | -4.48% |
| 2023 Q1 | 893.29 Million JPY | -4.29% |
| 2023 Q4 | 773.29 Million JPY | -4.92% |
| 2022 Q2 | 1.01 Billion JPY | 0.0% |
| 2022 Q3 | 973.3 Million JPY | -3.95% |
| 2022 Q4 | 933.3 Million JPY | -4.11% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | -0.816% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 61.335% |
| Linical Co., Ltd. | 1.49 Billion JPY | 48.445% |
| Trans Genic Inc. | 1.32 Billion JPY | 41.73% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -98913.06% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 67.053% |
| AnGes, Inc. | 214.94 Million JPY | -259.756% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -623.724% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 98.777% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -814.478% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 30.266% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -2622.667% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | 11.684% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -1880.261% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 57.927% |
| PeptiDream Inc. | 19.63 Billion JPY | 96.062% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -380.007% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -94.784% |
| Healios K.K. | 450 Million JPY | -71.843% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -900.494% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | 1.866% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | -57.381% |
| StemCell Institute Inc. | 6.67 Million JPY | -11483.164% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -437.942% |